- Book学术

发布求助

文献互助智能选刊最新文献

IF 0.4 4区哲学

Acta Bioethica Pub Date : 2020-09-25 DOI:10.12681/bioeth.24843

Nikolaos Kolisis (Νικόλαος Κολίσης)

引用次数: 0

摘要

CRISPR技术的发明及其目前和潜在的应用一直是科学家、哲学家和法律理论家争论的主题。在考虑了目前关于使用CRISPR编辑人类基因组的讨论之后，文章处理了公共医疗系统更广泛地提供基于CRISPR的治疗的问题，并提出了采用这种新工具所提供的新可能性的公平和经济可持续的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

CRISPR, μια νέα τεχνολογία γενετικής παρέμβασης: Πρόταση αξιοποίησης σε ένα δημόσιο σύστημα υγείας

The invention of CRISPR technology and its current and potential applications have been a subject of controversy among scientists, philosophers and legal theorists. After taking under consideration the current discussion concerning the use of CRISPR for editing human genome the article treats the question of a wider offer of CRISPR-based therapies from a Public Healthcare system and proposes method for a fair and financially sustainable way for adopting the new possibilities this new tool has to offer.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Acta Bioethica 医学-卫生政策

CiteScore

0.60

自引率

0.00%

发文量

审稿时长

1 months

期刊介绍： Acta Bioethica is a biannual publication by the Interdisciplinary Center for Studies in Bioethics of the University of Chile (ISSN 0717-5906, press edition, y 1726-569-X, electronic edition), which publishes in three languages: Spanish, English and Portuguese. Indexed in Science Citation Index (SCI), Scopus, Lilacs, SciELO y Latindex, and in database from several Institutions; it constitutes a pluralistic source of perspectives and an important tribune which accepts the contributions of authors compromised with the interdisciplinary study of ethical determinants and consequences of techno scientific research.